Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity.

BACKGROUND Innate immune activation, including a role for cluster of differentiation 14/toll-like receptor 4 co-receptors (CD14/TLR-4) co-receptors, has been implicated in paracrine damage to neurons in several neurodegenerative diseases that also display stratification of risk or clinical outcome with the common alleles of the apolipoprotein E gene (APOE): APOE2, APOE3, and APOE4. Previously, we have shown that specific stimulation of CD14/TLR-4 with lipopolysaccharide (LPS) leads to greatest innate immune response by primary microglial cultures from targeted replacement (TR) APOE4 mice and greatest p38MAPK-dependent paracrine damage to neurons in mixed primary cultures and hippocampal slice cultures derived from TR APOE4 mice. In contrast, TR APOE2 astrocytes had the highest NF-kappaB activity and no neurotoxicity. Here we tested the hypothesis that direct activation of CD14/TLR-4 in vivo would yield different amounts of paracrine damage to hippocampal sector CA1 pyramidal neurons in TR APOE mice. METHODS We measured in vivo changes in dendrite length in hippocampal CA1 neurons using Golgi staining and determined hippocampal apoE levels by Western blot. Neurite outgrowth of cultured primary neurons in response to astrocyte conditioned medium was assessed by measuring neuron length and branch number. RESULTS Our results showed that TR APOE4 mice had slightly but significantly shorter dendrites at 6 weeks of age. Following exposure to intracerebroventricular LPS, there was comparable loss of dendrite length at 24 hr among the three TR APOE mice. Recovery of dendrite length over the next 48 hr was greater in TR APOE2 than TR APOE3 mice, while TR APOE4 mice had failure of dendrite regeneration. Cell culture experiments indicated that the enhanced neurotrophic effect of TR APOE2 was LDL related protein-dependent. CONCLUSION The data indicate that the environment within TR APOE2 mouse hippocampus was most supportive of dendrite regeneration while that within TR APOE4 hippocampus failed to support dendrite regeneration in this model of reversible paracrine damage to neurons from innate immune activation, and suggest an explanation for the stratification of clinical outcome with APOE seen in several degenerative diseases or brain that are associated with activated innate immune response.

[1]  C. Colton,et al.  Apolipoprotein E-Derived Peptides Ameliorate Clinical Disability and Inflammatory Infiltrates into the Spinal Cord in a Murine Model of Multiple Sclerosis , 2006, Journal of Pharmacology and Experimental Therapeutics.

[2]  R. Mahley,et al.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[3]  T. Montine,et al.  Neurotoxicity from innate immune response is greatest with targeted replacement of ε4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  M. Vitek,et al.  Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic–ischemic injury , 2005, Neuroscience Letters.

[5]  T. Montine,et al.  CD14-Dependent Innate Immunity-Mediated Neuronal Damage in Vivo is Suppressed by NSAIDs and Ablation of a Prostaglandin E2 Receptor, EP2 , 2005 .

[6]  D. Schmechel,et al.  Marked regional differences of brain human apolipoprotein e expression in targeted replacement mice , 2004, Neuroscience.

[7]  T. Montine,et al.  Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment‐associated cytotoxicity , 2004, Journal of neurochemistry.

[8]  J. Haines,et al.  Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis , 2004, Neurogenetics.

[9]  J. Haines,et al.  Apolipoprotein E controls the risk and age at onset of Parkinson disease , 2004, Neurology.

[10]  E. Ongini,et al.  Attenuation of chronic neuroinflammation by a nitric oxide‐releasing derivative of the antioxidant ferulic acid , 2004, Journal of neurochemistry.

[11]  P. Matthews,et al.  Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE‐ε4 , 2004, Annals of neurology.

[12]  K. Ishii,et al.  The LPS receptor (CD14) links innate immunity with Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  D. Holtzman,et al.  Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients , 2003, Neuroscience.

[14]  M. Vitek,et al.  APOE Genotype and an ApoE-mimetic Peptide Modify the Systemic and Central Nervous System Inflammatory Response* , 2003, Journal of Biological Chemistry.

[15]  T. Montine,et al.  Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum , 2003, Journal of neurochemistry.

[16]  Shizuo Akira,et al.  Toll-like Receptor Signaling* , 2003, Journal of Biological Chemistry.

[17]  S. Rivest,et al.  Glucocorticoids Play a Fundamental Role in Protecting the Brain during Innate Immune Response , 2003, The Journal of Neuroscience.

[18]  Pamela L. Follett,et al.  Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  N. Nathoo,et al.  Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E , 2003, Molecular pathology : MP.

[20]  A. Roses,et al.  Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice , 2003, Neurobiology of Disease.

[21]  R. Pearlstein,et al.  Protective effect of apolipoprotein E-mimetic peptides on N-methyl-d-aspartate excitotoxicity in primary rat neuronal–glial cell cultures , 2003, Neuroscience.

[22]  T. Montine,et al.  Neuronal oxidative damage from activated innate immunity is EP2 receptor‐dependent , 2002, Journal of neurochemistry.

[23]  S. Rivest,et al.  Endotoxemia Prevents the Cerebral Inflammatory Wave Induced by Intraparenchymal Lipopolysaccharide Injection: Role of Glucocorticoids and CD141 , 2002, The Journal of Immunology.

[24]  C. Colton,et al.  APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress , 2002, Neurobiology of Aging.

[25]  B. Hauss-Wegrzyniak,et al.  Chronic Brain Inflammation Results in Cell Loss in the Entorhinal Cortex and Impaired LTP in Perforant Path-Granule Cell Synapses , 2002, Experimental Neurology.

[26]  Tony Wyss-Coray,et al.  Inflammation in Neurodegenerative Disease—A Double-Edged Sword , 2002, Neuron.

[27]  C. Colton,et al.  Apolipoprotein E isoform mediated regulation of nitric oxide release. , 2002, Free radical biology & medicine.

[28]  Gregory J. Brewer,et al.  Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein , 2002, Brain Research.

[29]  G. Getz,et al.  Apolipoprotein E and apolipoprotein E receptors modulate Aβ-induced glial neuroinflammatory responses , 2001, Neurochemistry International.

[30]  J. Hoffmann,et al.  Toll receptors in innate immunity. , 2001, Trends in cell biology.

[31]  M. Herkenham,et al.  Spatiotemporal induction patterns of cytokine and related immune signal molecule mRNAs in response to intrastriatal injection of lipopolysaccharide , 2000, Journal of Neuroimmunology.

[32]  A. Devitt,et al.  Macrophage recognition of ICAM-3 on apoptotic leukocytes. , 1999, Journal of immunology.

[33]  Lars Lannfelt,et al.  HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy , 1998, Nature Medicine.

[34]  N. Maeda,et al.  Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. , 1998, The Journal of clinical investigation.

[35]  A. Fagan,et al.  Glial Fibrillary Acidic Protein–Apolipoprotein E (apoE) Transgenic Mice: Astrocyte-Specific Expression and Differing Biological Effects of Astrocyte-Secreted apoE3 and apoE4 Lipoproteins , 1998, The Journal of Neuroscience.

[36]  R. Demattos,et al.  A Minimally Lipidated Form of Cell-derived Apolipoprotein E Exhibits Isoform-specific Stimulation of Neurite Outgrowth in the Absence of Exogenous Lipids or Lipoproteins* , 1998, The Journal of Biological Chemistry.

[37]  N. Maeda,et al.  Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis* , 1997, The Journal of Biological Chemistry.

[38]  N. Relkin,et al.  Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. , 1997, JAMA.

[39]  D. Holtzman,et al.  The Low‐Density Lipoprotein Receptor‐Related Protein, a Multifunctional Apolipoprotein E Receptor, Modulates Hippocampal Neurite Development , 1997, Journal of neurochemistry.

[40]  J. Xiang,et al.  BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Fagan,et al.  Apolipoprotein E-containing High Density Lipoprotein Promotes Neurite Outgrowth and Is a Ligand for the Low Density Lipoprotein Receptor-related Protein* , 1996, The Journal of Biological Chemistry.

[42]  R. Mahley,et al.  Stable Expression and Secretion of Apolipoproteins E3 and E4 in Mouse Neuroblastoma Cells Produces Differential Effects on Neurite Outgrowth (*) , 1995, The Journal of Biological Chemistry.

[43]  D. Holtzman,et al.  Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  W. Strittmatter,et al.  ApoE genotype and survival from intracerebral haemorrhage , 1995, The Lancet.

[45]  E Brisch,et al.  The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (*) , 1995, The Journal of Biological Chemistry.

[46]  H. deSilva,et al.  Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[47]  W. White,et al.  Predictors of cognitive decline after cardiac operation. , 1995, The Annals of thoracic surgery.

[48]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[49]  R. Mahley,et al.  Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.

[50]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[51]  T. Montine,et al.  Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice , 2006 .

[52]  David Sweeney,et al.  Similar promotion of Aβ1-42 fibrillogenesis by native apolipoprotein E ε3 and ε4 isoforms , 2004, Journal of Neuroinflammation.

[53]  J. Platt,et al.  Activation of mammalian Toll-like receptors by endogenous agonists. , 2003, Critical reviews in immunology.

[54]  A. Contestabile,et al.  Reciprocal Interactions Between Microglia and Neurons: From Survival to Neuropathology , 2002, Reviews in the neurosciences.

[55]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[56]  B. Dastugue,et al.  [Apolipoprotein E and Alzheimer's disease]. , 1998, Annales de biologie clinique.

[57]  S. Pizzo,et al.  Characterization of alpha 2-macroglobulin binding to human trabecular meshwork cells: presence of the alpha 2-macroglobulin signaling receptor. , 1996, Archives of biochemistry and biophysics.

[58]  D. Sholl.  Dendritic organization in the neurons of the visual and motor cortices of the cat. , 1953, Journal of anatomy.